- Home
- AEYE vs ACHV Comparison
AEYE vs ACHV Comparison
Compare AEYE & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEYE
- ACHV
- Stock Information
- Founded
- AEYE 2005
- ACHV N/A
- Country
- AEYE United States
- ACHV Canada
- Employees
- AEYE 117
- ACHV N/A
- Industry
- AEYE Computer Software: Prepackaged Software
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AEYE Technology
- ACHV Health Care
- Exchange
- AEYE Nasdaq
- ACHV Nasdaq
- Market Cap
- AEYE 138.0M
- ACHV 72.5M
- IPO Year
- AEYE N/A
- ACHV N/A
- Fundamental
- Price
- AEYE $11.92
- ACHV $2.43
- Analyst Decision
- AEYE Strong Buy
- ACHV Strong Buy
- Analyst Count
- AEYE 5
- ACHV 3
- Target Price
- AEYE $26.40
- ACHV $14.33
- AVG Volume (30 Days)
- AEYE 117.3K
- ACHV 181.0K
- Earning Date
- AEYE 04-29-2025
- ACHV 05-13-2025
- Dividend Yield
- AEYE N/A
- ACHV N/A
- EPS Growth
- AEYE N/A
- ACHV N/A
- EPS
- AEYE N/A
- ACHV N/A
- Revenue
- AEYE $36,851,000.00
- ACHV N/A
- Revenue This Year
- AEYE $20.29
- ACHV N/A
- Revenue Next Year
- AEYE $18.65
- ACHV N/A
- P/E Ratio
- AEYE N/A
- ACHV N/A
- Revenue Growth
- AEYE 16.52
- ACHV N/A
- 52 Week Low
- AEYE $8.91
- ACHV $1.84
- 52 Week High
- AEYE $34.85
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- AEYE 52.10
- ACHV 48.90
- Support Level
- AEYE $11.17
- ACHV $2.32
- Resistance Level
- AEYE $12.44
- ACHV $2.69
- Average True Range (ATR)
- AEYE 1.03
- ACHV 0.19
- MACD
- AEYE 0.09
- ACHV 0.03
- Stochastic Oscillator
- AEYE 74.46
- ACHV 64.38
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.